Re: AGM - Jan 7, 2016 - Details
in response to
by
posted on
Jan 15, 2016 09:24AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
PV Lee
You asked if Don meant end of Jan or Apr. He didn't "confirm" either. I took it to mean Q1 which would imply end of March 2016 to me.
masila